GSK (GSK)
NYSE: GSK
· Real-Time Price · USD
38.88
0.09 (0.23%)
At close: Aug 15, 2025, 9:58 AM
GSK Cash Flow Statement
Financials in GBP. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.65B | 1.77B | 501M | -58M | 1.17B | 1.05B | 350M | 1.53B | 1.75B | 1.63B | 1.63B | 779M | 350M | 2.17B | 930M | 1.37B | 1.54B | 1.26B |
Depreciation & Amortization | 1.16B | 823M | 412M | 951M | 639M | 549M | 1.18B | 579M | 452M | 640M | 7M | 956M | 631M | 704M | 513M | 986M | 664M | 361M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | 307M | n/a | n/a | n/a | 346M | n/a | n/a | n/a | 343M | n/a | n/a | n/a |
Other Working Capital | -1.03B | -788M | 3.76B | -714M | -322M | -607M | 2.95B | 164M | -1.99B | -840M | 1.36B | -469M | 473M | -174M | 2.04B | 50M | 115M | -1.38B |
Other Non-Cash Items | 322M | -662M | -2.34B | 1.98B | 992M | 753M | 2.85B | -65M | 1.1B | -1.38B | -227M | 55M | 181M | 342M | -663M | 76M | 250M | -751M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -865M | n/a | n/a | n/a | -784M | n/a | n/a | n/a | -1B | n/a | n/a | n/a |
Change in Working Capital | -1.03B | -788M | 3.76B | -714M | -644M | -311M | 1.81B | 164M | -1.99B | -840M | 938M | -469M | 473M | -671M | 2.99B | 132M | -1.16B | -539M |
Operating Cash Flow | 2.1B | 1.15B | 2.33B | 2.15B | 882M | 939M | 2.97B | 2.21B | 1.31B | 53M | 1.91B | 1.32B | 1.64B | 2.54B | 3.77B | 2.56B | 1.29B | 331M |
Capital Expenditures | -633M | -448M | -1.14B | -842M | -442M | -563M | -783M | -497M | -535M | -529M | -751M | -480M | -426M | -601M | -632M | -1.28B | -661M | -354M |
Cash Acquisitions | -36M | -826M | -96M | -17M | -33M | -721M | -2M | -73M | -542M | -52M | -6M | -2.99B | -73M | -70M | -33M | -34M | 337M | -85M |
Purchase of Investments | n/a | n/a | n/a | n/a | -32M | -18M | -31M | -33M | -3M | -56M | -22M | -63M | -14M | -45M | -16M | -24M | -20M | 18M |
Sales Maturities Of Investments | n/a | n/a | n/a | 57M | 1.24B | 1.08B | 1.02B | 72M | 799M | 11M | 1M | 114M | 1M | n/a | 7M | 24M | 404M | 62M |
Other Investing Acitivies | -333M | -110M | -479M | -466M | -3M | 24M | 756M | 40M | -683M | 218M | 238M | -678M | -33M | -2.92B | 304M | 135M | 139M | 311M |
Investing Cash Flow | -625M | -1.14B | -1.12B | -731M | 731M | -201M | 207M | -491M | -964M | -408M | -540M | -4.09B | -545M | -3.59B | -361M | -1.18B | -185M | -48M |
Debt Repayment | -874M | 1.92B | 244M | -548M | -539M | -323M | -2.77B | -1.04B | 1.04B | 408M | -406M | -1.15B | -2.82B | -51M | -1.42B | -226M | -347M | -49M |
Common Stock Repurchased | -561M | -247M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2M | n/a | n/a | 4M | -7M | n/a | n/a | n/a | n/a |
Dividend Paid | -656M | -612M | -612M | -612M | -652M | -568M | -568M | -567M | -557M | -555M | -654M | -705M | -1.16B | -952M | -951M | -951M | -1.15B | -946M |
Other Financial Acitivies | -283M | -213M | -474M | -81M | -124M | -116M | -255M | -151M | -451M | -177M | -278M | 522M | -521M | 8.97B | -407M | -218M | -551M | -396M |
Financial Cash Flow | -2.37B | 858M | -842M | -1.24B | -1.31B | -989M | -3.31B | -1.76B | 31M | -318M | -1.34B | -1.33B | -4.49B | 7.97B | -2.77B | -1.39B | -2.04B | -1.38B |
Net Cash Flow | -927M | 848M | 375M | 149M | 172M | -146M | -241M | -18M | 317M | -704M | 73M | -4.07B | -3.33B | 6.93B | 625M | -2M | -938M | -1.13B |
Free Cash Flow | 1.46B | 697M | 1.19B | 1.31B | 440M | 376M | 2.19B | 1.72B | 772M | -476M | 1.15B | 841M | 1.21B | 1.94B | 3.13B | 1.28B | 631M | -23M |